Notice of Closed Meeting, 13121 [2023-04241]
Download as PDF
<![CDATA[
13121
Federal Register / Vol. 88, No. 41 / Thursday, March 2, 2023 / Notices
EXHIBIT A.2—ESTIMATED ANNUALIZED COST BURDEN—Continued
Number of
respondents *
Form name
2. AHRQ Office Readiness Survey (cancer diagnostic process cohort only)
3. AHRQ Patient Safety Culture Surveys:
a. MOSOPS (both cohorts):
i. Physicians ....................................................................................
ii. Other Health Practitioners ...........................................................
b. Diagnostic Safety Supplement (cancer diagnostic process cohort
only):
i. Physicians ....................................................................................
ii. Other Health Practitioners ...........................................................
4. Participant Experience Survey (both cohorts) ...........................................
5. Semi-structured qualitative interviews (both cohorts) ...............................
6. Clinical Data Collection Form (cancer diagnostic process cohort only) ...
7. EHR data (AS cohort only) ........................................................................
Total ........................................................................................................
Average
hourly wage
rate **
Total burden
hours
Total
burden
cost
350
35
a 111.30
3,896
466
467
466
467
a 111.30
51,866
14,566
175
175
200
24
90
150
70
70
54
24
1,604
2,700
a 111.30
a 111.30
7,791
2,183
6,010
2,671
178,525
300,510
3,497
5,917
........................
576,922
b 31.19
b 31.19
a 111.30
a 111.30
a 111.30
** Annualized number of respondents is based on maximum practices recruited and 75% response rate for forms 1 and 4, 50% response rate
for forms 2, 3a and 3b, and 90% response rate for forms 5–7.
** National Compensation Survey: Occupational wages in the United States May 2021 ‘‘U.S. Department of Labor, Bureau of Labor Statistics’’:
https://www.bls.gov/oes/current/oes_stru.htm#29-0000.
a Based on the mean wages for 29–1069 Physicians and Surgeons, All Other.
b Based on the mean wages for 29–9099 Miscellaneous Health Practitioners and Technical Workers: Healthcare Practitioners and Technical
Workers, All Other.
Request for Comments
ddrumheller on DSK120RN23PROD with NOTICES1
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3520,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) whether the
proposed collection of information is
necessary for the proper performance of
AHRQ’s health care research and health
care information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: February 23, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–04220 Filed 3–1–23; 8:45 am]
BILLING CODE 4160–90–P
VerDate Sep<11>2014
18:21 Mar 01, 2023
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
GH23–003, Conducting Public Health
Research with Universities in Thailand.
Date: April 12, 2023.
Time: 9 a.m.–2:30 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Hylan Shoob, Ph.D., Scientific Review
Officer, Center for Global Health, CDC,
1600 Clifton Road NE, Mailstop H21–9,
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Atlanta, Georgia 30329–4027;
Telephone: (404) 639–4796; Email:
HShoob@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–04241 Filed 3–1–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
E:\FR\FM\02MRN1.SGM
02MRN1
]]>Agencies
[Federal Register Volume 88, Number 41 (Thursday, March 2, 2023)]
[Notices]
[Page 13121]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04241]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)-GH23-003, Conducting Public Health
Research with Universities in Thailand.
Date: April 12, 2023.
Time: 9 a.m.-2:30 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Hylan Shoob, Ph.D., Scientific
Review Officer, Center for Global Health, CDC, 1600 Clifton Road NE,
Mailstop H21-9, Atlanta, Georgia 30329-4027; Telephone: (404) 639-4796;
Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04241 Filed 3-1-23; 8:45 am]
BILLING CODE 4163-18-P
